SCHEMBL3975633

SCHEMBL3975633

O=C(Nc1ccc(-c2cccc(OC(Cc3ccccc3)C(=O)O)c2)cc1)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 18/20 0.59
PPARA Q07869 16/20 0.59
HDAC1 Q13547 1/20 0.54
PGR P06401 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3974615 0.94 PPARG (0.68) PPARGPPARAHDAC1PGR
SCHEMBL5983770 0.84 PPARG (0.55) PPARGPPARA
SCHEMBL3970004 0.83 PPARG (0.64) PPARGPPARA
SCHEMBL3973228 0.81 PPARG (0.61) PPARGPPARA
SCHEMBL3978911 0.78 KDM4E (0.52) PPARGPPARAHDAC1
SCHEMBL3972386 0.78 PPARG (0.56) PPARGPPARA
SCHEMBL3980861 0.78 PPARG (0.56) PPARGPPARAHDAC1
SCHEMBL5983805 0.77 PPARG (0.48) PPARGPPARA
SCHEMBL3974851 0.77 PPARG (0.48) PPARGPPARA
SCHEMBL3978857 0.77 PPARG (0.53) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667959-A1 BIPHENYLOXY-ACIDS Wyeth (US) 2006-06-14 EP claimed
WO-2005030702-A1 BIPHENYLOXY-ACIDS WYETH (US) 2005-04-07 WO claimed
US-7534894-B2 Biphenyloxy-acids WYETH (US) 2009-05-19 US disclosed
EP-1667959-A1 BIPHENYLOXY-ACIDS Wyeth (US) 2006-06-14 EP disclosed
US-20060020003-A1 Biphenyloxy-acids WYETH (US) 2006-01-26 US disclosed
WO-2005030702-A1 BIPHENYLOXY-ACIDS WYETH (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020003-A1 Biphenyloxy-acids AHR, ARNT, NR1H4 PPARG 88/4885PPARA 30/4885HDAC1 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.